Catheter Precision, Inc. Reports Results of Special Shareholder Meeting: Multiple Proposals Approved

Catheter Precision, Inc. (NYSE American: VTAK) has announced the results of its Special Meeting of Shareholders held on April 15, 2026. This meeting, which had a record date of March 9, 2026, saw the representation of 1,165,698 shares out of a total 2,357,127 outstanding shares of common stock, amounting to approximately 49.5% participation by eligible voting shares.

Key Points and Potentially Price-Sensitive Information

• Approval of Multiple Capital Structure Proposals:
  • Proposal 1: Shareholders approved the issuance of common stock underlying the conversion of Series C-1, C-2, C-3, and C-4 convertible preferred stock. This move enables the company to potentially increase its outstanding shares, which could affect future earnings per share and the dilution of existing shareholders.
  • Proposal 2: Approval was granted for the issuance of shares from the conversion of Series D convertible preferred stock, further increasing the flexibility for capital raising and restructuring.
  • Proposal 3: The company received approval for the issuance of shares underlying Series J convertible preferred stock, continuing the trend of capital structure expansion.
  • Proposal 4: Shareholders voted to allow the issuance of additional shares as a result of the reduction in the conversion price of the currently outstanding Series B convertible preferred stock. This could lead to an increase in outstanding shares if holders convert at lower prices, leading to dilution but potentially strengthening the balance sheet.
• Reverse Stock Split Authorization:
  • Proposal 5: The company now has authorization from shareholders to amend its Certificate of Incorporation to effect a reverse stock split at a ratio ranging from 1-for-2 to 1-for-100, at the discretion of the Board of Directors. A reverse stock split can be a significant event for investors as it may enhance the company’s share price, maintain listing requirements, or reduce volatility. However, it does not change the underlying value of the company and may signal efforts to stabilize or improve market perception.
• Ongoing Flexibility to Adjourn Meetings:
  • Proposal 6: Shareholders approved the company’s ability to adjourn or postpone the Special Meeting to continue soliciting votes for the above proposals if needed, providing strategic flexibility to ensure the passage of key initiatives.

Detailed Voting Results

What Shareholders Should Know

• The approval of multiple proposals related to convertible preferred stock provides the company with increased financial flexibility, but also introduces the possibility of significant dilution for existing common shareholders, which may impact share value.
• The authorization for a reverse stock split is a major corporate action and could affect the trading price of Catheter Precision’s shares. While it can help maintain compliance with exchange listing standards and attract institutional investors, it does not change the company’s market capitalization.
• The relatively low participation (49.5%) in voting may suggest a need for enhanced shareholder engagement.

Additional Company Information

• Company Name: Catheter Precision, Inc.
• Trading Symbol: VTAK
• Exchange: NYSE American
• Business Address: 1670 Highway 160 West, Suite 205, Fort Mill, SC 29708
• Corporate Structure: Incorporated in Delaware (DE)
• Formerly known as: Ra Medical Systems, Inc.

Disclaimer: This article is based on the company’s SEC Form 8-K filing dated April 15, 2026. The information herein is for informational purposes only and does not constitute investment advice. Investors are encouraged to review the full SEC filing and consult with a qualified financial advisor before making investment decisions. Stock price movements are influenced by a variety of factors, and past actions may not predict future performance.

View Catheter Precision, Inc. Historical chart here